Newsfeeds - Spark Newswire

4 minute read

Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday’s Mid-Day Session

Today, 1:55 PM

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery.

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 1:55 PM

Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 127.8% to $5.04 during Tuesday’s regular session. As of 12:30…

ACHV

1 minute read

Cowen & Co. Downgrades Macrogenics to Market Perform

By Benzinga Newsdesk

Today, 1:55 PM

Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.

MGNX

2 minute read

First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles

By Vandana Singh

Today, 1:55 PM

The FDA approved Provention Bio Inc’s (NASDAQ:PRVB) Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in…

MGNX

1 minute read

Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session

By Lisa Levin

Today, 1:55 PM

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

AMAT

1 minute read

MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences

By Lisa Levin

Today, 1:55 PM

BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares gained 3.5% to trade at $6.97 on Monday.

AIRS